|
Neuland Laboratories Ltd.
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
18073.46 Cr.
|
P/BV
|
11.16
|
Book Value (Rs.)
|
1,262.74
|
|
52 Week High/Low (Rs.)
|
19747/10191
|
FV/ML
|
10/1
|
P/E(X)
|
69.48
|
|
Bookclosure
|
18/07/2025
|
EPS (Rs.)
|
202.74
|
Div Yield (%)
|
0.09
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 1434.38 | 1515.66 | 1160.90 | 923.33 | 918.18 |
| Other Operating Revenues | 42.46 | 42.92 | 30.30 | 27.74 | 18.74 |
| Total Operating Revenues | 1476.84 | 1558.58 | 1191.20 | 951.08 | 936.91 |
| | | | | | |
| Other Income | 20.51 | 12.54 | 9.75 | 2.08 | 16.10 |
| Total Revenue | 1497.35 | 1571.12 | 1200.95 | 953.15 | 953.01 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 574.81 | 632.43 | 487.74 | 437.55 | 439.66 |
| Operating And Direct Expenses | 162.87 | 156.51 | 135.56 | 131.36 | 120.29 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | 12.83 | -55.14 | -9.51 | -15.41 | -1.24 |
| Employee Benefit Expenses | 272.00 | 257.06 | 201.79 | 182.47 | 149.74 |
| Finance Costs | 8.30 | 14.00 | 13.07 | 13.50 | 17.90 |
| Depreciation And Amortisation Expenses | 65.55 | 59.70 | 52.78 | 49.04 | 39.68 |
| Other Expenses | 131.06 | 105.13 | 103.78 | 72.48 | 81.66 |
| Total Expenses | 1227.42 | 1169.69 | 985.20 | 870.99 | 847.67 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 269.93 | 401.44 | 215.75 | 82.16 | 105.33 |
| | | | | | |
| Exceptional Items | 76.40 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit/Loss Before Tax | 346.33 | 401.44 | 215.75 | 82.16 | 105.33 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | 73.77 | 99.67 | 50.44 | 20.43 | 12.56 |
| Deferred Tax | 12.45 | 1.69 | 1.79 | -2.09 | 12.15 |
| Total Tax Expenses | 86.22 | 101.36 | 52.23 | 18.34 | 24.70 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 260.11 | 300.08 | 163.52 | 63.82 | 80.63 |
| | | | | | |
| Profit/Loss From Continuing Operations | 260.11 | 300.08 | 163.52 | 63.82 | 80.63 |
| | | | | | |
| Profit/Loss For The Period | 260.11 | 300.08 | 163.52 | 63.82 | 80.63 |
| Consolidated Profit/Loss After MI And Associates | 260.11 | 300.08 | 163.52 | 63.82 | 80.63 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | 202.74 | 233.89 | 127.45 | 49.74 | 62.85 |
| Diluted EPS (Rs.) | 202.74 | 233.89 | 127.45 | 49.74 | 62.85 |
| | | | | | |
| DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
| Equity Share Dividend | 17.96 | 12.83 | 6.41 | 3.85 | 2.57 |
